Search

everythinglearnresearchcommunity

for

Search:↓

SHBG may be a useful early indicator and treatment target for PCOS.

The document concludes that a deeper understanding of skin aging and photodamage is needed to create better skin treatments.

Telogen effluvium is a common hair loss condition where many hairs enter the resting phase, often not noticeable until significant loss occurs, and treatment focuses on the underlying cause.

The document concludes that Borrelia afzelii causes a skin condition in France, a gene is linked to hair loss in Caucasian women, and various genetic mutations affect skin diseases.

Cicatricial alopecia, a permanent hair loss condition, is mainly caused by damage to specific hair follicle stem cells and abnormal immune responses, with gene regulator PPAR-y and lipid metabolism disorders playing significant roles.

The document reports findings on genetic research, including ethical concerns about genome editing, improved diagnosis of mitochondrial mutations, solving inherited eye diseases, confirming gene roles in epilepsy, linking a gene to aneurysms, and identifying genes associated with age-related macular degeneration.

The document concludes that the development of certain tumors is influenced by genetic background and that a specific gene modification can lead to tumor regression and reduced growth.

Some medications can cause hair loss, and it's important to track when the hair loss starts after taking a new medication.

Early signs of PCOS in girls, like irregular periods and polycystic ovaries, suggest a need for early diagnosis and intervention to prevent further health issues.

Hair loss in Androgenetic alopecia (AGA) is due to altered cell sensitivity to hormones, not increased hormone levels. Hair growth periods shorten over time, causing hair to become thinner and shorter. This is linked to miscommunication between cell pathways in hair follicles. There's also a change in gene expression related to blood vessels and cell growth in balding hair follicles. The exact molecular causes of AGA are still unclear.

Chemotherapy causes complex changes in hair follicle cells that can lead to hair loss.

Special particles from umbilical cord stem cells help heal skin wounds in diabetic mice by preventing certain immune cell death.

Genes linked to fibrosis are more active in people with central centrifugal cicatricial alopecia.

Social media can help compare the effectiveness and safety of new arthritis medications.

Scientists now better understand the genetics of hypohidrotic ectodermal dysplasia, leading to more accurate diagnoses and potential new treatments.

miRNA-based therapies show promise for treating skin diseases, including hair loss, in animals.

The vitamin D receptor is crucial for bone health and affects various body systems, with mutations potentially leading to disease.

Beta-caryophyllene helps improve wound healing in mice, especially in females.

Some medications can cause hair loss, but stopping the drug usually leads to recovery within 3 months.

PCOS may start before birth, involves metabolic issues, and can be treated with drugs like metformin and lifestyle changes.

Mesenchymal stromal cells may help treat severe COVID-19, but more research is needed to confirm their effectiveness.

Advanced therapies like gene, cell, and tissue engineering show promise for hair regrowth in alopecia, but their safety and effectiveness need more verification.

Putting thymidine dinucleotide on newborn mice's skin can delay and reduce skin cancer.

Beta-caryophyllene, found in essential oils, helps wounds heal better in multiple ways.

Animal models, especially mice, are essential for advancing hair loss research and treatment.

Melanocytes produce melanin; their defects cause vitiligo and hair graying, with treatments available for vitiligo.

The nucleus is key in controlling skin growth and repair by coordinating signals, gene regulators, and epigenetic changes.

Blocking IL-12/IL-23 does not help with hair loss in alopecia areata for mice or humans.

CRAC channels are crucial for the development and function of specialized immune cells, preventing severe inflammation and autoimmune diseases.

Wound covers with α-13'-COOH from vitamin E can improve and speed up wound healing.